3751 - 3775 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Allosteric inhibition of LRRK2, where are we nowJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 48Issue #: 5Start Page: 2185End Page: 2194Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bst20200424Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/48/5/2185/896516/bst-2020-0424c.pdfCitation Count: 10
-
RESTRICTEDTitle: Apolipoprotein E ε4 genotype and risk of freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 173End Page: 178Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.033Citation Count: 17
-
OPENTitle: Detect and correct bias in multi-site neuroimaging datasetsJournal Name: Medical Image AnalysisPublisher: Elsevier BVVol: 67Issue #:Start Page: 101879End Page: 101879Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.media.2020.101879Best OA location URL: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdfCitation Count: 85
-
OPENTitle: Microgravity: A Tool for Protein Drug DevelopmentJournal Name: International Journal of Pharmaceutical Sciences Review and ResearchPublisher: Global Research OnlineVol: 64Issue #: 2Start Page: 82End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.47583/ijpsrr.2020.v64i02.014Best OA location URL: https://doi.org/10.47583/ijpsrr.2020.v64i02.014Citation Count: 2
-
OPENTitle: Palliative Care for Persons Living With Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 324Issue #: 15Start Page: 1579End Page: 1579Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2020.18333Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2771904/jama_sokol_2020_pg_200052_1602876114.33828.pdfCitation Count: 5
- Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany2020OPENTitle: Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in GermanyJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 78Issue #: 3Start Page: 1137End Page: 1148Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-200794Citation Count: 6
-
OPENTitle: What's happening in Neurology ® Clinical PracticeJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 16Start Page: 727End Page: 727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010792Best OA location URL: https://n.neurology.org/content/neurology/95/16/727.full.pdfCitation Count: 0
- Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology2020OPENTitle: Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 3Start Page: 489End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12211Best OA location URL: https://doi.org/10.1002/alz.12211Citation Count: 22
-
OPENTitle: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2134End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28354Best OA location URL: https://eprints.ncl.ac.uk/file_store/production/271876/552911A9-469D-41EA-AA8A-F7B7D5C04187.pdfCitation Count: 4
- A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease2020OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 16
- Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regions2020OPENTitle: Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regionsJournal Name: Clinical EpigeneticsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13148-020-00944-zBest OA location URL: https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-020-00944-zCitation Count: 58
-
OPENTitle: Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2020Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/1694547Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/1694547.pdfCitation Count: 12
- Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality Mapping2020OPENTitle: Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality MappingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.554660Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.554660/pdfCitation Count: 6
-
RESTRICTEDTitle: Inflammatory bowel disease and Parkinson’s disease: common pathophysiological linksJournal Name: GutPublisher: BMJVol:Issue #:Start Page: gutjnlEnd Page: 322429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/gutjnl-2020-322429Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/663875/2/gutjnl-2020-322429_main_18_Aug_clean.pdfCitation Count: 93
- Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal2020RESTRICTEDTitle: Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personalJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-020-00218-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-020-00218-xCitation Count: 29
- Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology2020OPENTitle: Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and PathologyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.577435Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.577435/pdfCitation Count: 54
-
RESTRICTEDTitle: Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian SyndromesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.572976Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.572976/pdfCitation Count: 72
-
OPENTitle: Robust Bayesian Analysis of Early-Stage Parkinson’s Disease Progression Using DaTscan ImagesJournal Name: IEEE Transactions on Medical ImagingPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 40Issue #: 2Start Page: 549End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/tmi.2020.3031478Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899013Citation Count: 7
-
RESTRICTEDTitle: Effect of sex on aging-related decline of dopamine transporter in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 1Start Page: 76End Page: 82Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-020-01538-8Citation Count: 6
- Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease2020OPENTitle: Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-74195-6Best OA location URL: https://www.nature.com/articles/s41598-020-74195-6.pdfCitation Count: 28
- Pilot Evaluation of a Pragmatic Network for Integrated Care and Self‐Management in Parkinson's Disease2020RESTRICTEDTitle: Pilot Evaluation of a Pragmatic Network for Integrated Care and Self‐Management in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 398End Page: 406Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28332Citation Count: 17
-
OPENTitle: A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerabilityJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 69End Page: 74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770052Citation Count: 20
- Bundle analytics, a computational framework for investigating the shapes and profiles of brain pathways across populations2020OPENTitle: Bundle analytics, a computational framework for investigating the shapes and profiles of brain pathways across populationsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-74054-4Best OA location URL: https://www.nature.com/articles/s41598-020-74054-4.pdfCitation Count: 82
-
RESTRICTEDTitle: History of and Insights Into Spinal Cord Stimulation in Parkinson DiseaseJournal Name: Neurorehabilitation and Neural RepairPublisher: SAGE PublicationsVol: 34Issue #: 11Start Page: 967End Page: 978Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1545968320956984Citation Count: 3
- A detailed life history of a pleistocene steppe bison (Bison priscus) skeleton unearthed in Arctic Alaska2020OPENTitle: A detailed life history of a pleistocene steppe bison (Bison priscus) skeleton unearthed in Arctic AlaskaJournal Name: Quaternary Science ReviewsPublisher: Elsevier BVVol: 249Issue #:Start Page: 106578End Page: 106578Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.quascirev.2020.106578Best OA location URL: https://munin.uit.no/bitstream/10037/20794/2/article.pdfCitation Count: 12